Share issues

OrganoClick has in recent years established a strong position as a green chemical company with biobased chemical products that replace “hidden” plastics and harmful chemicals in fibre-based materials such as textiles, nonwovens and wood.

In order to strengthen the financial position, reduce interest expenses and create conditions to maximise the Company’s growth opportunities and thereby achieve profitable growth, OrganoClick is now carrying out a rights issue of approximately SEK 39.6 million (the “Rights Issue”). The Rights Issue is secured to approximately 75 percent through subscription commitments from the Company’s major shareholders and a majority of the Company’s board members.

The Company’s consumer brands OrganoTex and BIOkleen within the Consumer Applications business area have shown positive sales development. Within the Wood Protection business area, our brand OrganoWood with its exposure to the construction market has faced challenges. With very good results from the five-year field studies for our new wood protection technology, the goal is now to license out the timber production, which creates conditions for a more efficient and scalable business model.

For the Nonwoven Technologies business area with our biobased binders, the focus going forward is on the several customer projects close to commercialisation which also entail a broadening of the customer base with new applications, such as food absorbents and wet wipes.

The Rights Issue strengthens OrganoClick’s prospects of creating value for customers, shareholders and the environment.

Over the past three years the Group has experienced positive sales growth for its consumer products within the Consumer Applications business area but negative sales development within the Wood Protection and Nonwoven Technologies business areas. In order to bring the Company to profitable growth, a savings programme of SEK 20 million was implemented during the autumn of 2025. This is now being expanded by a further approximately SEK 5 million in reduced operating costs. In recent years the Company has also accumulated a debt burden that generates annual interest expenses of just over SEK 5 million, which limits the Company’s financial flexibility.

The Board of Directors considers that a reduction of the debt burden, combined with targeted investments in sales and marketing, is crucial for turning the Company towards profitable growth. By reducing interest expenses, the Company’s ongoing results will improve materially, while strategic investments in sales and marketing activities create conditions for increased revenues and long-term sustainable profitability. To achieve increased sales, we are focusing primarily on the following three activities over the coming 12–18 months:

1. Continue to drive growth for our consumer brands OrganoTex and BIOkleen

Over the past three years the Company has continued its international expansion of its consumer brand OrganoTex. OrganoTex is currently the only brand globally that offers 100% biobased and biodegradable textile and footwear impregnations, replacing PFAS and synthetic plastic polymers used in competing solutions.  OrganoTex has developed strongly with an average annual sales growth of 16% over the past three years, driven by both strong new customer sales and growth among existing customers.

OrganoTex has now been launched in the Nordic countries, Benelux, Germany, Switzerland, Italy, Poland and Austria through partnerships with distributors and leading outdoor chains. In Sweden the brand has a strong position with retailers such as Naturkompaniet, Team Sportia, Sportringen, Hööks, Jaktia and the golf chain Dormy. The Company’s ambition is to leverage the brand’s current unique position through continued international expansion and through growth in existing markets. For OrganoTex, the focus in the coming year will be on continued establishment and market penetration in the Nordic countries, the Alpine region and DACH.

Our consumer brand BIOkleen, which offers eco-labelled maintenance products for wooden structures, houses and properties, has also developed strongly. Sales have grown continuously over the past three years through new retailers such as Bauhaus, Hornbach and Beijer Byggmaterial in Sweden. For BIOkleen, the focus will be on continued establishment and sales growth in the Nordic countries.

2. Focus on customer projects within new applications for our biobased binders for nonwovens

For the Company’s biobased binders for industrial nonwoven textiles, a number of customer projects with significant economic potential are ongoing. We have several customer projects with leading nonwoven manufacturers where production tests are in progress. The purpose of all projects is to replace current plastic binders with our bio-based binders so that the material becomes 100% biobased, compostable and plastic-free. We are also working to reduce the production cost of our binders in order to be able to compete with plastic binders in more price-sensitive segments. The new applications that are close to commercialisation are:

Our ambition is to complete these projects so that our customers can launch their products within 12 months, which will drive sales growth for our binders.

3. Licensing of the Group’s Nordic Swan eco-labelled wood protection technology

The Company’s strategy is to become a pure green chemical company. Currently the Group manufactures and sells ready-treated timber treated with our Nodic Swan eco-labelled wood protection technology. During the spring of 2026 the Group received results from the five-year field test CEN/TS 12037 conducted by the Danish Technological Institute in Malaysia and Denmark, which showed the highest class of rot protection. With these results as a basis, the Group’s manufacturing and sale of the finished timber is to be licensed out to wood treatment companies while we continue to manufacture and deliver wood protection chemical to these parties. This will reduce the Group’s revenue but increase profitability and scalability through a uniform, less capital-intensive business model and reduced operational costs.

Through the Rights Issue the Company will receive net proceeds of approximately SEK 39 million after issue costs. Given the Company’s current business plan and against the above background, the Company will use the expected net proceeds as follows:

By implementing the above-mentioned measures, the Company’s balance sheet will be strengthened with improved equity ratio and lower leverage, while conditions are created for sustainable growth and profitability.

Below you find the Information memorandum which OrganoClick has published in front of the Rights Issue, including description of the company and our business, full motive for the Rights Issue, Use of proceeds and instruction for subscription of shares.

In order to subscribe for a different number of shares than the number of subscription rights, please use the Subscripion form below or follow his link to subscribe digitally https://app.verified.eu/web/eminova-app/?company=organoclick2026

Information memorandum Rights issue OrganoClick AB June 2026

Subscription form

.